Christopher Upton

Array ( [id] => 6688333 [patent_doc_number] => 20030032058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Protein-protein interactions' [patent_app_type] => new [patent_app_number] => 10/014814 [patent_app_country] => US [patent_app_date] => 2001-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10752 [patent_no_of_claims] => 171 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032058.pdf [firstpage_image] =>[orig_patent_app_number] => 10014814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507082 [patent_doc_number] => 06440720 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator' [patent_app_type] => B1 [patent_app_number] => 10/013784 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13029 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440720.pdf [firstpage_image] =>[orig_patent_app_number] => 10013784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697726 [patent_doc_number] => 20030109920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Engineered animal tissue' [patent_app_type] => new [patent_app_number] => 10/012194 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13139 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109920.pdf [firstpage_image] =>[orig_patent_app_number] => 10012194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6526092 [patent_doc_number] => 20020192665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition' [patent_app_type] => new [patent_app_number] => 10/004717 [patent_app_country] => US [patent_app_date] => 2001-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 36598 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192665.pdf [firstpage_image] =>[orig_patent_app_number] => 10004717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6486393 [patent_doc_number] => 20020152493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Transgenic mice containing PTP36 tyrosine phosphatase gene disruptions' [patent_app_type] => new [patent_app_number] => 10/005467 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20413 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20020152493.pdf [firstpage_image] =>[orig_patent_app_number] => 10005467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5927039 [patent_doc_number] => 20020116729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Transgenic mice containing NTTP1 phosphatase gene disruptions' [patent_app_type] => new [patent_app_number] => 10/005858 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19831 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20020116729.pdf [firstpage_image] =>[orig_patent_app_number] => 10005858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6557975 [patent_doc_number] => 20020194636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Transgenic mice containing polycystin-related gene disruptions' [patent_app_type] => new [patent_app_number] => 10/005211 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20316 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20020194636.pdf [firstpage_image] =>[orig_patent_app_number] => 10005211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985160 [patent_doc_number] => 20020098223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Biocompatible implant for the expression and in vivo secretion of a therapeutic substance' [patent_app_type] => new [patent_app_number] => 09/987601 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11718 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098223.pdf [firstpage_image] =>[orig_patent_app_number] => 09987601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861092 [patent_doc_number] => 20030092100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Tn7 transposition method for producing mutant genes' [patent_app_type] => new [patent_app_number] => 10/010288 [patent_app_country] => US [patent_app_date] => 2001-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8977 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092100.pdf [firstpage_image] =>[orig_patent_app_number] => 10010288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5927040 [patent_doc_number] => 20020116730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Transgenic mice containing PERK protein kinase gene disruptions' [patent_app_type] => new [patent_app_number] => 10/005983 [patent_app_country] => US [patent_app_date] => 2001-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20009 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20020116730.pdf [firstpage_image] =>[orig_patent_app_number] => 10005983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683323 [patent_doc_number] => 20030119187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Antigen presenting cells, method for their preparation and their use for cancer vaccines' [patent_app_type] => new [patent_app_number] => 09/981239 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10033 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119187.pdf [firstpage_image] =>[orig_patent_app_number] => 09981239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6086143 [patent_doc_number] => 20020083481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Vectors and methods for the mutagenesis of mammalian genes' [patent_app_type] => new [patent_app_number] => 09/982586 [patent_app_country] => US [patent_app_date] => 2001-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8867 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20020083481.pdf [firstpage_image] =>[orig_patent_app_number] => 09982586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828214 [patent_doc_number] => 20020068274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Novel method for assessing recoding in vitro and in vivo' [patent_app_type] => new [patent_app_number] => 09/981393 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11755 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068274.pdf [firstpage_image] =>[orig_patent_app_number] => 09981393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1053441 [patent_doc_number] => 06858772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-22 [patent_title] => 'Transgenic mice containing magnesium-dependent protein phosphatase gene disruptions' [patent_app_type] => utility [patent_app_number] => 09/972741 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20390 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858772.pdf [firstpage_image] =>[orig_patent_app_number] => 09972741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1275807 [patent_doc_number] => 06637366 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Nematode biopesticide' [patent_app_type] => B1 [patent_app_number] => 09/869080 [patent_app_country] => US [patent_app_date] => 2001-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4058 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/637/06637366.pdf [firstpage_image] =>[orig_patent_app_number] => 09869080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5971866 [patent_doc_number] => 20020092034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Non-human model of gestational and adult folate deficiency and uses thereof' [patent_app_type] => new [patent_app_number] => 09/962290 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14923 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20020092034.pdf [firstpage_image] =>[orig_patent_app_number] => 09962290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6175586 [patent_doc_number] => 20020155421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Endothelial cell mitogen bioassay' [patent_app_type] => new [patent_app_number] => 09/961128 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4228 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155421.pdf [firstpage_image] =>[orig_patent_app_number] => 09961128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861175 [patent_doc_number] => 20030092183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Rapid creation of gene targeting vectors using homologous recombination in yeast' [patent_app_type] => new [patent_app_number] => 09/961163 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11391 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092183.pdf [firstpage_image] =>[orig_patent_app_number] => 09961163 [rel_patent_id] =>[rel_patent_doc_number] =>)